Operating Lease, Right-of-Use Asset of Theriva Biologics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Theriva Biologics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Theriva Biologics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $803,000, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Theriva Biologics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $803,000 -$469,000 -37% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 $942,000 -$486,000 -34% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,077,000 -$442,000 -29% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,171,000 -$463,000 -28% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,272,000 -$487,000 -28% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 $1,428,000 -$403,000 -22% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,519,000 -$437,000 -22% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,634,000 -$420,000 -20% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,759,000 +$560,000 +47% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $1,831,000 +$585,000 +47% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,956,000 +$664,000 +51% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $2,054,000 +$716,000 +54% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,199,000 -$184,000 -13% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $1,246,000 -$180,000 -13% 30 Sep 2022 10-K 30 Mar 2023 2022 FY
Q2 2022 $1,292,000 -$176,000 -12% 30 Jun 2022 10-K 30 Mar 2023 2022 FY
Q1 2022 $1,338,000 +$1,099,000 +460% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,383,000 +$1,104,000 +396% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,426,000 +$1,110,000 +351% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $1,468,000 +$1,116,000 +317% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $239,000 -$147,000 -38% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $279,000 -$140,000 -33% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $316,000 -$135,000 -30% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $352,000 -$129,000 -27% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $386,000 -$124,000 -24% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $419,000 +$419,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $451,000 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 $481,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $510,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 20 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.